Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Chimeric virus-like particles presenting tumour-associated MUC1 epitope result in high titers of specific IgG antibodies in the presence of squalene oil-in-water adjuvant: towards safe cancer immunotherapy

Fig. 1

Construction of chimeric VLPs presenting tumour MUC1 epitope. A Schematic representation of cloning of tumour-associated MUC1 epitope into NoV VP1 gene. B Predicted presentation of MUC1 epitope on the surface of VLPs. C Western blotting analysis of the chimeric NoV VP1-MUC1 expressed in the LEXSY expression system in reducing conditions. The protein was detected as a 70 kDa band in cell lysates using specific anti-MUC1 antibodies and anti-NoV antibodies. WT (wild type) L. tarentolae cell lysates and NoV VP1 L. tarentolae cell lysates served as controls

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us